logo

For the Inventor, By the Inventor

Murray Hill, NJ, United States of America

Ginny Dai Ho

This inventor holds 17 USPTO granted patents and 1 published patent application and 5 EPO patents, primarily in Nociceptin Receptor Ligands. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp.. Active years: 2001-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ginny Dai Ho. Retrieved from https://idiyas.com/inventor/ginny-dai-ho

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 64.7

 

Average Co-Inventor Count = 6.9

ph-index = 4

Forward Citations = 99(Granted Patents)


Company Filing History:

goldMedal9 out of 1,829 
 
Schering Corporation
 patents
silverMedal8 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents

Years Active: 2001-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Nociceptin Receptor
Taro Inhibitors
IRAK4 Activity
Benzimidazoles
Indoles
Oxazolidinones
Amidopyrazoles
Triazolopyridines
Tropane Derivatives
Azetidinyl Diamines
High Affinity Ligands
Heteroaryl Tropane
17 patents (USPTO):Explore Patents
1. 11752128 - Benzimidazoles and indoles as taro inhibitors (2023-09-12),
2. 11738010 - Oxazolidinones as TarO inhibitors (2023-08-29),
3. 11141410 - Oxazolidinones as taro inhibitors (2021-10-12),
4. 11141403 - Benzimidazoles and indoles as taro inhibitors (2021-10-12),
5. 10155765 - Carboxamide inhibitors of IRAK4 activity (2018-12-18),
6. 9598440 - Inhibitors of IRAK4 activity (2017-03-21),
7. 9169260 - Amidopyrazole inhibitors of interleukin receptor-associated kinases (2015-10-27),
8. 8685967 - Substituted triazolopyridines and analogs thereof (2014-04-01),
9. 7910603 - 3-monosubstituted tropane derivatives as nociceptin receptor ligands (2011-03-22),
10. 7485650 - High affinity ligands for nociceptin receptor ORL-1 (2009-02-03),
11. 7479494 - 3-monosubstituted tropane derivatives as nociceptin receptor ligands (2009-01-20),
12. 7094784 - High affinity ligands for nociceptin receptor ORL-1 (2006-08-22),
13. 6903123 - Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1 (2005-06-07),
14. 6727254 - Heteroaryl tropane derivatives as superior ligands for nociceptin receptor ORL-1 (2004-04-27),
15. 6716846 - High affinity ligands for nociceptin receptor ORL-1 (2004-04-06),

Title: Ginny Dai Ho: A Trailblazer in Innovation and Patent Creation

Introduction:

Ginny Dai Ho, a visionary inventor based in Murray Hill, NJ (US), has captured the essence of innovation through her relentless pursuit of new ideas. Her passion for pushing boundaries and exploring novel concepts has made her a pioneering figure in the world of inventions and patents.

Latest Patents:

With an impressive portfolio of 17 patents, Ginny Dai Ho continues to make groundbreaking contributions to the field of pharmaceuticals. Her latest patents, "Benzimidazoles and indoles as TarO inhibitors" and "Oxazolidinones as TarO inhibitors," showcase her expertise in developing compounds that inhibit TarO and combat bacterial infections, including MRSA and MRSE.

Career Highlights:

Having worked at renowned companies such as Schering Corporation and Merck Sharp & Dohme Corporation, Ginny Dai Ho has honed her skills and expertise in the pharmaceutical industry. Her innovative approach to research and development has led to significant advancements in the prevention and treatment of various diseases.

Collaborations:

Throughout her career, Ginny Dai Ho has collaborated with esteemed professionals in the field, including Deen Tulshian and Zheng Tan. These collaborations have not only enriched her work but have also paved the way for new discoveries and inventions in the pharmaceutical sector.

Conclusion:

Ginny Dai Ho's unwavering dedication to innovation and her remarkable contributions to the field of patents have left an indelible mark on the world. Her work continues to inspire the next generation of inventors, highlighting the transformative power of creativity and perseverance in driving meaningful change.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…